AGL 38.80 Decreased By ▼ -0.78 (-1.97%)
AIRLINK 131.00 Decreased By ▼ -0.22 (-0.17%)
BOP 6.97 Increased By ▲ 0.16 (2.35%)
CNERGY 4.62 Decreased By ▼ -0.09 (-1.91%)
DCL 8.42 Decreased By ▼ -0.02 (-0.24%)
DFML 41.40 Decreased By ▼ -0.07 (-0.17%)
DGKC 81.50 Decreased By ▼ -0.59 (-0.72%)
FCCL 32.80 Decreased By ▼ -0.30 (-0.91%)
FFBL 72.75 Decreased By ▼ -0.12 (-0.16%)
FFL 12.50 Increased By ▲ 0.24 (1.96%)
HUBC 110.50 Decreased By ▼ -0.24 (-0.22%)
HUMNL 14.13 Decreased By ▼ -0.38 (-2.62%)
KEL 5.13 Decreased By ▼ -0.06 (-1.16%)
KOSM 7.68 Increased By ▲ 0.07 (0.92%)
MLCF 38.69 Decreased By ▼ -0.21 (-0.54%)
NBP 69.02 Increased By ▲ 5.01 (7.83%)
OGDC 190.60 Decreased By ▼ -2.22 (-1.15%)
PAEL 25.54 Decreased By ▼ -0.14 (-0.55%)
PIBTL 7.55 Increased By ▲ 0.21 (2.86%)
PPL 151.52 Decreased By ▼ -2.55 (-1.66%)
PRL 25.54 Decreased By ▼ -0.29 (-1.12%)
PTC 17.57 Decreased By ▼ -0.24 (-1.35%)
SEARL 81.39 Decreased By ▼ -0.91 (-1.11%)
TELE 7.68 Decreased By ▼ -0.08 (-1.03%)
TOMCL 32.95 Decreased By ▼ -0.51 (-1.52%)
TPLP 8.39 Decreased By ▼ -0.10 (-1.18%)
TREET 16.93 Increased By ▲ 0.31 (1.87%)
TRG 58.25 Increased By ▲ 0.85 (1.48%)
UNITY 28.11 Increased By ▲ 0.60 (2.18%)
WTL 1.34 Decreased By ▼ -0.03 (-2.19%)
BR100 10,573 Increased By 68.2 (0.65%)
BR30 31,082 Decreased By -144.7 (-0.46%)
KSE100 99,066 Increased By 986 (1.01%)
KSE30 30,932 Increased By 373.4 (1.22%)
Markets

Brazil's Hapvida approves potential $470mn share offering

  • The offering would combine primary and follow-on offerings, Hapvida said in Sunday's filing, adding that it would use the proceeds of the primary offering to finance current and future acquisitions.
Published April 12, 2021

SAO PAULO: Brazilian healthcare provider Hapvida has approved a share offering that could raise as much as 2.68 billion reais ($471.72 million) after it is priced on April 20, the company said in a securities filing.

The offering would combine primary and follow-on offerings, Hapvida said in Sunday's filing, adding that it would use the proceeds of the primary offering to finance current and future acquisitions.

Comments

Comments are closed.